Labshake search
Citations for TriLink BioTechnologies :
1 - 7 of 7 citations for Mouse Anti Rubella virus Glycoprotein E2 1717 since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Microbiology 2020Quote: ... Virus was plaque-purified on Vero CCL81 cells in the presence of 25 μg/ml of cytosine arabinoside (TriLink BioTechnologies), and plaques in agarose plugs were amplified on Vero CCL81 cells ...
-
bioRxiv - Bioengineering 2023Quote: ... All saRNA templates were generated from a plasmid encoding NSP1-4 of the Venezuela Equine Encephalitis Virus (VEEV) under either a CleanCap AU (TriLink BioTechnologies) compatible T7 promoter (Promoter seq ...
-
bioRxiv - Immunology 2019Quote: ... Mouse C57BL/6 zygotes (Taconic) were injected with a mix of Cas9 mRNA (Trilink Biotechnologies) (100 ng/uL ...
-
bioRxiv - Synthetic Biology 2021Quote: ... 6 mM Anti Reverse Cap Analog (TriLink BioTechnologies), and the template DNA ...
-
bioRxiv - Immunology 2022Quote: ... including an Anti-Reverse Cap Analog (ARCA, Trilink BioTechnologies), and chemically modified N1-methylpseudouridine-5’-triphosphate (Trilink BioTechnologies ...
-
bioRxiv - Immunology 2020Quote: ... Anti-Reverse Cap Analog (ARCA, Trilink Biotechnologies, San Diego, USA) was used for mRNA capping ...
-
bioRxiv - Immunology 2023Quote: ... an anti-reverse capping analogue (Trilink Biotechnologies, San Diego, CA, USA), N1-methylpseudouridine (Sapala Organics Private Limited ...